Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilda Mennen

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infectionThandeka Moyo-Gwete, Simone I Richardson, Roanne Keeton, et al.
Cell Reports. Medicine|April 27, 2022
Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concernDale Kitchin, Simone I Richardson, Mieke A van der Mescht, et al.
Science Translational Medicine|December 21, 2021
Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunityCatherine Riou, Roanne Keeton, Thandeka Moyo-Gwete, et al.
Iscience|January 18, 2024
Distinct T cell polyfunctional profile in SARS-CoV-2 seronegative children associated with endemic human coronavirus cross-reactivityNtombi Benede, Marius B Tincho, Avril Walters, et al.
Cell Host & Microbe|October 24, 2021
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent mannerRoanne Keeton, Simone I Richardson, Thandeka Moyo-Gwete, et al.
Nature|February 1, 2022
T cell responses to SARS-CoV-2 spike cross-recognize OmicronRoanne Keeton, Marius B Tincho, Amkele Ngomti, et al.
Nature|April 9, 2022
Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize OmicronRoanne Keeton, Marius B Tincho, Amkele Ngomti, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infectionThandeka Moyo-Gwete, Simone I Richardson, Roanne Keeton, et al.
Cell Reports. Medicine|April 27, 2022
Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concernDale Kitchin, Simone I Richardson, Mieke A van der Mescht, et al.
Science Translational Medicine|December 21, 2021
Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunityCatherine Riou, Roanne Keeton, Thandeka Moyo-Gwete, et al.
Iscience|January 18, 2024
Distinct T cell polyfunctional profile in SARS-CoV-2 seronegative children associated with endemic human coronavirus cross-reactivityNtombi Benede, Marius B Tincho, Avril Walters, et al.
Cell Host & Microbe|October 24, 2021
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent mannerRoanne Keeton, Simone I Richardson, Thandeka Moyo-Gwete, et al.
Nature|February 1, 2022
T cell responses to SARS-CoV-2 spike cross-recognize OmicronRoanne Keeton, Marius B Tincho, Amkele Ngomti, et al.
Nature|April 9, 2022
Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize OmicronRoanne Keeton, Marius B Tincho, Amkele Ngomti, et al.
Pageof 2